Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mar 26, 2009

Premium

The Howard Hughes Medical Institute announced that Stanford University researcher Howard Chang has been appointed to a six-year term as part of the inaugural class of Howard Hughes Medical Institute Early Career Scientists.

Chang, an associate professor of dermatology, will receive $1.5 million over six years to support his research into the function of long, non-coding RNAs, according to HHMI.


Traversa Therapeutics has appointed two new members to its scientific advisory board.

Joining the SAB are William Kaelin, a professor of medicine at the Dana-Farber Cancer Institute and Brigham and Women's Hospital, and Yitzhak Tor, a professor of chemistry and biochemistry at the University of California, San Diego.